Bojan Cercek MD , Ph.D

Adult Congenital Heart Disease

Professor, Medicine, UCLA School of Medicine

8700 Beverly BlvdLos Angeles, CA 90048
Phone+1 310-967-1884
Fax+1 310-967-1744

Dr. Cercek is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cercek's full profile Already have an account?

Education & Training

Cedars-Sinai Medical CenterResidency, Internal Medicine, 1988 - 1989
Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1985 - 1988
University of Ljubljana Faculty of MedicineClass of 1974

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1988 - 2027
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017

Publications & Presentations

PubMed

Impaired CD4T cell response to apolipoprotein B-100 peptide P210 in atherosclerotic cardiovascular disease is reversed by P210-conjugated nanoparticles.
Paul C Dimayuga, Jianchang Zhou, Xiaoning Zhao, Janet Wei, Noah Trac
American Journal of Physiology. Heart and Circulatory Physiology. 2026-10-01
LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults.
Paul C Dimayuga, Jianchang Zhou, Xiaoning Zhao, Kuang-Yuh Chyu, Prediman K Shah
Physiological Reports. 2026-06-01
Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypes.
Paul C Dimayuga, Kuang-Yuh Chyu, Jianchang Zhou, Xiaoning Zhao, Janet Wei
Clinical & Translational Immunology. 2026-01-01

Journal Articles

The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification
Fernando Chernomordik, Bojan Cercek, Kuang-Yuh Chyu, Prediman K Shah, Frontiers in Immunology

Press Mentions

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsJanuary 4th, 2019
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for PatientsJanuary 1st, 2019
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline fo...March 10th, 2016